MIRA Pharmaceuticals, Inc.
MIRANASDAQHealthcareDrug Manufacturers - General
As of Oct 15, 2026 close
- Market cap
- $27.65M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.60$2.45
- Volume (live)
- -
- Avg. volume (3M)
- 168.85K
MIRA Pharmaceuticals (MIRA) Stock Price & Financial Analysis
MIRA Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.63 - $0.68 |
|---|---|
| 52-Week High | $2.45 |
| 52-Week Low | $0.60 |
| Open | $0.64 |
| Volume (last close) | 128.63K |
| Average Volume (3M) | 168.85K |
| 50-Day MA | $0.77 |
|---|---|
| 200-Day MA | $1.02 |
| 1-Year Change | −63.44% |
| Market Cap | 27.65M |
|---|---|
| Shares Outstanding | 42.02M |
| Price to Book (P/B) | 3.39 |
| EV/EBITDA | -2.59 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
MIRA Pharmaceuticals at a Glance
As of the Oct 15, 2026 close, MIRA Pharmaceuticals (MIRA) has a market capitalization of $27.65M.
As of its latest reported balance sheet, it holds $3.61M in cash and securities against $0.00 of debt, a net cash position of $3.61M.
MIRA Pharmaceuticals does not currently pay a dividend.
The share price is down 63.4% over the past year. At $0.66 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.60 to $2.45, below its 200-day moving average of $1.02.
Frequently Asked Questions About MIRA Pharmaceuticals
What is the current stock price for MIRA?
As of the Oct 15, 2026 close, MIRA stock trades at $0.66. The 52-week range is $0.60–$2.45, with a day range of $0.63–$0.68.
What is the P/E ratio for MIRA?
The P/E ratio (Price-to-Earnings) for MIRA is shown in the Key Statistics section. This valuation metric helps compare MIRA Pharmaceuticals, Inc. to industry peers.
Does MIRA pay dividends?
MIRA Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MIRA?
Analyst ratings and recommendations for MIRA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of MIRA?
As of the Oct 15, 2026 close, MIRA Pharmaceuticals's market capitalization is $27.7M, classifying it as a micro-cap company. MIRA Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - General industry.